CTL019 in pediatric and young adult relapsed/refractory acute lymphoblastic leukemia (ALL) patients
Challenges and future perspectives for minimal residual disease (MRD) in multiple myeloma
Bruno Paiva et al.
How the treatment of AML will change
Mary Frances McMullin
MRD studies in ALL and AML
Exploring the potential of T-cell therapy for acute lymphoblastic leukemia